Nvidia to Invest $1 Billion in AI Drug Laboratory With Eli Lilly

Nvidia Corp. plans to invest $1 billion over five years in a new laboratory with Eli Lilly & Co., aiming to speed up the use of artificial intelligence in the pharmaceutical industry. The facility will be built in Silicon Valley and bring Lilly’s lab expertise closer to the center of artificial inte...

Redirecting to full article...